Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy PDS Biotechnology Corporation stock | $11.58

Learn how to easily invest in PDS Biotechnology Corporation stock.

PDS Biotechnology Corporation is a biotechnology business based in the US. PDS Biotechnology Corporation shares (PDSB) are listed on the NASDAQ and all prices are listed in US Dollars. PDS Biotechnology Corporation employs 15 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in PDS Biotechnology Corporation

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PDSB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

PDS Biotechnology Corporation stock price (NASDAQ: PDSB)

Use our graph to track the performance of PDSB stocks over time.

PDS Biotechnology Corporation shares at a glance

Information last updated 2021-10-18.
Latest market close$11.58
52-week range$1.87 - $17.85
50-day moving average $14.91
200-day moving average $10.45
Wall St. target price$19.71
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.53

Buy PDS Biotechnology Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy PDS Biotechnology Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PDS Biotechnology Corporation price performance over time

Historical closes compared with the close of $11.58 from 2021-10-21

1 week (2021-10-15) -6.08%
1 month (2021-09-22) -27.58%
3 months (2021-07-22) 12.10%
6 months (2021-04-22) 115.64%
1 year (2020-10-22) 421.62%
2 years (2019-10-22) 273.55%
3 years (2018-10-22) 1,444.00%
5 years (2016-10-21) 6.63%

PDS Biotechnology Corporation financials

Gross profit TTM $0
Return on assets TTM -20.63%
Return on equity TTM -25.71%
Profit margin 0%
Book value $2.57
Market capitalisation $350.5 million

TTM: trailing 12 months

Shorting PDS Biotechnology Corporation shares

There are currently 489,087 PDS Biotechnology Corporation shares held short by investors – that's known as PDS Biotechnology Corporation's "short interest". This figure is 10.2% up from 443,869 last month.

There are a few different ways that this level of interest in shorting PDS Biotechnology Corporation shares can be evaluated.

PDS Biotechnology Corporation's "short interest ratio" (SIR)

PDS Biotechnology Corporation's "short interest ratio" (SIR) is the quantity of PDS Biotechnology Corporation shares currently shorted divided by the average quantity of PDS Biotechnology Corporation shares traded daily (recently around 489087). PDS Biotechnology Corporation's SIR currently stands at 1. In other words for every 100,000 PDS Biotechnology Corporation shares traded daily on the market, roughly 1000 shares are currently held short.

However PDS Biotechnology Corporation's short interest can also be evaluated against the total number of PDS Biotechnology Corporation shares, or, against the total number of tradable PDS Biotechnology Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PDS Biotechnology Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 PDS Biotechnology Corporation shares in existence, roughly 20 shares are currently held short) or 0.0195% of the tradable shares (for every 100,000 tradable PDS Biotechnology Corporation shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PDS Biotechnology Corporation.

Find out more about how you can short PDS Biotechnology Corporation stock.

PDS Biotechnology Corporation share dividends

We're not expecting PDS Biotechnology Corporation to pay a dividend over the next 12 months.

Have PDS Biotechnology Corporation's shares ever split?

PDS Biotechnology Corporation's shares were split on a 1:20 basis on 17 March 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PDS Biotechnology Corporation shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for PDS Biotechnology Corporation shares which in turn could have impacted PDS Biotechnology Corporation's share price.

PDS Biotechnology Corporation share price volatility

Over the last 12 months, PDS Biotechnology Corporation's shares have ranged in value from as little as $1.87 up to $17.85. A popular way to gauge a stock's volatility is its "beta".

PDSB.US volatility(beta: 2)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PDS Biotechnology Corporation's is 2.0048. This would suggest that PDS Biotechnology Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.

PDS Biotechnology Corporation overview

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U. S. Department of Health and Human Services, and MSD International GmbH.

Frequently asked questions

What percentage of PDS Biotechnology Corporation is owned by insiders or institutions?
Currently 21.317% of PDS Biotechnology Corporation shares are held by insiders and 20.92% by institutions.
How many people work for PDS Biotechnology Corporation?
Latest data suggests 15 work at PDS Biotechnology Corporation.
When does the fiscal year end for PDS Biotechnology Corporation?
PDS Biotechnology Corporation's fiscal year ends in December.
Where is PDS Biotechnology Corporation based?
PDS Biotechnology Corporation's address is: 25B Vreeland Road, Florham Park, NJ, United States, 07932
What is PDS Biotechnology Corporation's ISIN number?
PDS Biotechnology Corporation's international securities identification number is: US70465T1079
What is PDS Biotechnology Corporation's CUSIP number?
PDS Biotechnology Corporation's Committee on Uniform Securities Identification Procedures number is: 279870109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site